AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Obrascon Huarte Lain S.A.

M&A Activity Nov 24, 2020

1870_rns_2020-11-24_274bef7a-a08e-4cc9-b24f-a9068e79152d.html

M&A Activity

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2502G

Obrascon Huarte Lain, S.A.

24 November 2020

London Stock Exchange

Madrid, November 23rd 2020

Ref.: Toledo Hospital

Dear Sirs,

OBRASCON HUARTE LAIN, S.A. ("OHL" or the "Company"), pursuant to article 226 of the consolidated text of the Spanish Securities Market Act approved by Royal Legislative Decree 4/2015, of 23 October, hereby notifies the Spanish National Securities Market Commission (Comisión Nacional del Mercado de Valores) ("CNMV") the following

INSIDE INFORMATION

The Company informs that today has signed a contract for the sale of shares and assignment of receivables in relation to the sale of the following stakes to a fund managed by DIF Capital Partners: (i) 33.34% of the share capital of Nuevo Hospital de Toledo S.A. and (ii) 100% of the share capital of Mantohledo S.A.U. ("the Transaction"). The initial sale price of the Transaction has been set at seventy-six million one hundred thirty thousand euros (€76,130,000.00), a price that will be increased by a variable amount of interest that will be calculated based on the closing date and the settlement of the transaction. The closing and settlement of the transaction are subject to obtaining the authorizations and satisfaction of customary closing conditions of this type of deals.

José María del Cuvillo Pemán
Secretary of the Board of Directors

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCXXLLLBFLEFBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.